Abstract - 603255 Disclosed is the compound 2-(3-(cyclopropylmethyl)-2-oxo-imidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of the compound 2-(3-(cyclopropylmethyl)-2-oxoimidazolidin-1-yl)-4-methyl-N-(pyridin-3-ylmethyl)thiazole-5-carboxamide or a pharmaceutically acceptable salt thereof optionally in combination with a therapeutic...

Processes for preparing pravastatin intermediates and pharmaceutically acceptable salts thereof are provided Crystalline forms of pravastatin intermediates and pharmaceutically acceptable salts thereof are also disclosed.

The present invention relates to a salt of a carboxylic acid with a diamine such as 22'-(ethylenedioxy)diethyl amine 33'-(ethylenedioxy)dipropyl amine and 22'-oxybis(ethylamine) and a method of preparing such salts. Preferably the carboxylic acid is a fermentation product such as clavulanic acid mycophenolic acid or pravastatin.